androgen receptor antagonist ONC1-0013B
Term · Oncology and biomedicine · MLC-T-ONC-010065
An orally bioavailable antagonist of the androgen receptor (AR), with potential antineoplastic activity. Upon oral administration, AR antagonist ONC1-13B specifically binds to AR, prevents AR activation, downregulates AR expression and prevents AR-mediated signaling. This inhibits cell growth in AR-overexpressing tumor cells. AR is overexpressed in prostate cancers and is involved in proliferation, survival and chemoresistance of tumor cells.
| Identifier | MLC-T-ONC-010065 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | AR antagonist ONC1-0013B |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010065",
"term": "androgen receptor antagonist ONC1-0013B",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable antagonist of the androgen receptor (AR), with potential antineoplastic activity. Upon oral administration, AR antagonist ONC1-13B specifically binds to AR, prevents AR activation, downregulates AR expression and prevents AR-mediated signaling. This inhibits cell growth in AR-overexpressing tumor cells. AR is overexpressed in prostate cancers and is involved in proliferation, survival and chemoresistance of tumor cells.",
"synonyms": [
"AR antagonist ONC1-0013B"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/androgen-receptor-antagonist-onc1-0013b/"
}
Record 1,073 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.